Skip to main content

Table 2 Eradication rates in groups of active and placebo probiotic

From: Association of a probiotic to a Helicobacter pylorieradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study

Probiotic

Active (CI 95%)

Placebo (CI 95%)

p

Per protocol

89.8% (81-99%)

85.1% (75-96%)

p = 0.49

Intention to treat

81.8% (71-92%)

76.9% (65-89%)

p = 0.53

  1. Pearson Chi-Square.
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us